EcoDrugPlus

Dna Methyltransferase 1

Ensembl ID : ENSSFOG00015023715
Gene Symbol: DNMT1
3 Cross references
210 Possible Orthologues:

Dna Topoisomerase I

Ensembl ID : ENSSFOG00015021061
Gene Symbol: TOP1
1 Cross references
207 Possible Orthologues:

Dna Topoisomerase I

Ensembl ID : ENSSFOG00015021646
Gene Symbol: TOP1
3 Cross references
198 Possible Orthologues:

Dna Topoisomerase Ii Alpha

Ensembl ID : ENSSFOG00015005389
Gene Symbol: TOP2A
1 Cross references
209 Possible Orthologues:

Dna Topoisomerase Ii Beta

Ensembl ID : ENSSFOG00015014944
Gene Symbol: TOP2B
3 Cross references
208 Possible Orthologues:

E-Selectin-Like

Ensembl ID : ENSSFOG00015006094
Gene Symbol: LOC108934974
2 Cross references
126 Possible Orthologues:

Emap Like 4

Ensembl ID : ENSSFOG00015000647
Gene Symbol: EML4
3 Cross references
210 Possible Orthologues:

Eph Receptor A3

Ensembl ID : ENSSFOG00015023035
Gene Symbol: EPHA3
3 Cross references
213 Possible Orthologues:

Eph Receptor A3

Ensembl ID : ENSSFOG00015005561
Gene Symbol: EPHA3
1 Cross references
213 Possible Orthologues:

F2r Like Thrombin Or Trypsin Receptor 3

Ensembl ID : ENSSFOG00015002782
Gene Symbol: F2RL3
3 Cross references
195 Possible Orthologues:

Fau Ubiquitin Like And Ribosomal Protein S30 Fusion

Ensembl ID : ENSSFOG00015019676
Gene Symbol: FAU
3 Cross references
20 Possible Orthologues:

Fyn Proto-Oncogene, Src Family Tyrosine Kinase

Ensembl ID : ENSSFOG00015013610
Gene Symbol: FYN
3 Cross references
132 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).